Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Triple Paste is a premium consumer healthcare brand specializing in medicated ointments for the treatment and prevention of diaper rash and skin irritation. Originally developed by Summers Laboratories and now owned by Advantice Health, the brand is widely recognized for its Triple Paste Diaper Rash Cream, a zinc oxide-based topical treatment. The product line is formulated to provide a long-lasting barrier for sensitive skin and is frequently recommended by pediatricians and dermatologists. The company focuses on the over-the-counter (OTC) dermatological market, providing relief for infants and adults with compromised skin barriers. Its portfolio has expanded to include antifungal treatments and sheer zinc formulations to meet diverse consumer needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Triple Paste.